Label all vials clearly with the compound name, concentration, date of preparation, and expiry date, in accordance with Good Laboratory Practice (GLP) and Good Clinical Practice (GCP) requirements
Retatrutide produces greater weight loss at every comparable timepoint, despite using a lower maximum dose (12 mg versus 15 mg)
As we move toward a future of DOWNSIZED metabolic footprints, the data suggests that Retatrutide will play a pivotal role
In the placebo group, typical total consumption over 30 days declined by 46%, much less but still a substantial amount, reflecting the placebo effect, the desire to reduce drinking, and the fact that participants received CBT therapy over the course of the trial
The clinical role of the TME in solid cancer